EUVIMEDEUVIMED entdecken
Crossref

Genomic Characterization of Papillary Thyroid Cancer Reveals Germline Mutations Associated With Congenital Hypothyroidism

Vaishakhi Trivedi, Hitesh Kore iD, Disha Poojary iD, Vanita Noronha iD, Munita Bal iD, Pratik Chandrani iD, Anuradha Choughule iD, Priyanka Pange, Vinod Gupta, Nandini Menon iD, Vijay Patil iD, Minit Shah iD und 3 weitere

JCO Global Oncology · 2025

DOI: 10.1200/go-25-00043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, 2025. Verfasst von Vaishakhi Trivedi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tata Memorial Hospital, Parel, India. Hauptthemen laut MEDLINE: Germ-Line Mutation, Congenital Hypothyroidism, Thyroid Cancer, Papillary, Thyroid Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Thyroid dyshormonogenesis, a form of congenital hypothyroidism, is characterized by defects in thyroid hormone synthesis genes, affecting both children and adults. However, the potential link between such genetic defects and the development of papillary thyroid cancer (PTC) remains unclear. METHODS We conducted whole-exome sequencing on 100 (N = 100) tumor-normal paired and orphan tumor samples of PTC from Indian patients, characterizing both germline and somatic molecular alterations. RESULTS We identified significant germline mutations in the DUOX2 gene (approximately 8.8%), commonly associated with congenital hypothyroidism and thyroid dyshormonogenesis, and found these mutations to correlate with poor prognosis in PTC. Additionally, hallmark somatic mutations were detected in genes such as BRAF (35.4%), KRAS (3.8%), HRAS (5.1%), and NRAS (17.7%), which are well-known drivers of PTC. Importantly, we identified a distinct molecular subtype termed independent of BRAF-RAS (iBR), characterized by nonhallmark alterations and associated with a higher recurrence rate and poorer recurrence-free survival in Indian patients with PTC, highlighting the clinical significance of these molecular insights in prognosis and treatment strategies. CONCLUSION Our analysis of PTC among Indians revealed novel genetic alterations and molecular subtypes. We identified a germline mutation in the DUOX2 gene, associated with congenital hypothyroidism, as a potential risk factor of PTC. Additionally, we characterized distinct molecular subtypes, BRAF-RAS driven and iBR driven, and their clinical implications. These findings provide valuable insights into the genetic landscape of thyroid cancer in Indian patients and offer potential avenues for targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationCongenital HypothyroidismThyroid Cancer, PapillaryThyroid NeoplasmsHumansMaleFemaleAdultDual OxidasesChildAdolescentMiddle AgedYoung AdultGenomicsExome SequencingPrognosis

Substanzen

Dual OxidasesDUOX2 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Tata Memorial Hospital, Parel, India.
  • Homi Bhabha National Institute, Training School Complex, Mumbai, India.
  • Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Australia.
  • Medical Oncology Molecular Laboratory, Tata Memorial Hospital, Parel, India.
  • Department of Pathology, Tata Memorial Hospital, Parel, India.
  • Centre for Computational Biology, Bioinformatics and Crosstalk Lab, Advanced Centre for Treatment, Research, and Education in Cancer, Kharghar, India.

ORCID-Profile: Hitesh Kore, Disha Poojary, Vanita Noronha, Munita Bal, Pratik Chandrani, Anuradha Choughule, Nandini Menon, Vijay Patil, Minit Shah, Pankaj Chaturvedi, Kumar Prabhash

Zitieren

APA

Trivedi, V., Kore, H., Poojary, D., Noronha, V., Bal, M., Chandrani, P., Choughule, A., Pange, P., Gupta, V., Menon, N., Patil, V., Shah, M., Chaturvedi, P., Prabhash, K., & Dutt, A. (2025). Genomic Characterization of Papillary Thyroid Cancer Reveals Germline Mutations Associated With Congenital Hypothyroidism. JCO Global Oncology. https://doi.org/10.1200/go-25-00043

Vancouver

Trivedi V, Kore H, Poojary D, Noronha V, Bal M, Chandrani P, et al. Genomic Characterization of Papillary Thyroid Cancer Reveals Germline Mutations Associated With Congenital Hypothyroidism. JCO Global Oncology. 2025. doi:10.1200/go-25-00043

BibTeX
@article{Trivedi2025,
  author = {Trivedi, Vaishakhi and Kore, Hitesh and Poojary, Disha and Noronha, Vanita and Bal, Munita and Chandrani, Pratik and Choughule, Anuradha and Pange, Priyanka and Gupta, Vinod and Menon, Nandini and Patil, Vijay and Shah, Minit and Chaturvedi, Pankaj and Prabhash, Kumar and Dutt, Amit},
  title = {Genomic Characterization of Papillary Thyroid Cancer Reveals Germline Mutations Associated With Congenital Hypothyroidism},
  journal = {JCO Global Oncology},
  year = {2025},
  doi = {10.1200/go-25-00043}
}
Kostenlos starten →